PhaseWell Research (“PhaseWell”), a multisite clinical research company, announces the strategic acquisition of Chase Medical Research (“CMR”). Under the leadership of founder, key opinion leader, and lead Principal Investigator Dr. Joseph Soufer, CMR operates sites in Waterbury and Hamden, Connecticut. The addition of Chase Medical Research strengthens PhaseWell’s growing Northeast footprint and significantly expands the company’s cardiometabolic capabilities while offering complimentary expansion within its growing central nervous system portfolio.
Read the full article: PhaseWell Research Acquires Chase Medical Research to Expand Clinical Trial Capabilities in Connecticut //
Source: https://www.businesswire.com/news/home/20260318898091/en/PhaseWell-Research-Acquires-Chase-Medical-Research-to-Expand-Clinical-Trial-Capabilities-in-Connecticut